Erin Blanchfield accepts public warning from USADA for failure to obtain TUE


UFC Flyweight Up-and-Comer Erin Blanchfield received a USADA public warning for a violation of their anti-doping policy.

Blanchfield did not apply for a Therapeutic Use Exemption (TUE). She used topical spironolactone as a prescription drug that is banned in the United States. This was according to USADA.

Spironolactone is commonly used to treat acne but is prohibited year-round by USADA for its uses as a diuretic and masking agent. After accepting the warning from USADA officials, Blanchfield was granted a TUE to cover her topical use of spironolactone.

Blanchfield is currently tied as MMA Fighting’s No. 14 is the highest ranked female flyweight worldwide. She is considered a promising prospect in the 125-pound Division. Her UFC career has been successful with wins over Sarah Alpar, Miranda Maverick and other 2-0 fighters.

The USADA will not affect

Blanchfield’s fight against JJ Altrich scheduled for June 4 UFC Vegas 56,.